StemGenex provides stem cell therapy for people suffering from degenerative and inflammatory illnesses. They sponsor five clinical studies registered with the National Institutes of Health for Multiple Sclerosis(MS), Parkinson's Disease, Rheumatoid Arthritis, Chronic Obstructive Pulmonary Disease, and Osteoarthritis. The StemGenex Medical Group provides stem cell therapy for people affected by Multiple Sclerosis which damages the "myelin sheath" protecting nerve cells in the brain and spinal cord. StemGenex offers treatment for MS by introducing adult mesenchymal stem cells past the blood brain barrier. There the stem cells transform into and repair the myelin sheath nerve cells, a process called remyelination The mesenchymal stem cells can repair the immune system to keep it from attacking itself in a process called immunomodulation. Through these processes, StemGenex works to improve the lives of people affected by Multiple Sclerosis.

The UC Davis stem cell program works to advance stem cell therapies for patients and families who suffer from chronic disease or injury. The institute is housed in a 92,000 square-foot area which includes a Good Manufacturing Practice(GMP). The GMP is a highly specialized laboratory which allows researchers to conduct safe clinical trials for human patients. UC Davis ranks among the top institutions in the state for research funds. 

The Stem Cell Institute of America trains physicians in communities all over America in the benefits of stem cells so they can better inform the general public. Their goal is public education on how patients can live a life without pain with stem cell medicine. Through their educational workshops, they teach local organizations, businesses, churches, and local clubs about how stem cells work, the different types of stem cells, and research studies. 

​

​

(Text 16)

The Harvard Stem Cell Institute is a community of scientists and clinical experts that work to bring new treatments and save lives by treating a wide range of chronic illnesses. The Harvard community is composed of the largest concentration of biomedical researchers in the world and they work daily to advance the clinic treatments for diseases of aging, the blood, metabolism, and neurological diseases. Through the Seed Grants and Junior Faculty Program, the HSCI contributes funding for "high risk" research that has difficulty finding funding from other sources. 

​

(Text 15)

The National Institutes of Health(NIH) is a part of the U.S Department of Health and Human Services. NIH is the medical research agency of the nation and is credited for vital discoveries that improve health and save lives. NIH has 27 different institutes with specific research agendas including stem cell therapies. NIH research has been making greater advancements in studies of the three different types of stem cells and making patient-specific cells for more detailed studies of many diseases. Researchers at NIH are working to use stem cells as a way to study neurological diseases like Parkinson's, Huntington's, amyotrophic lateral scelerosis(ALS), and spinal cord injury. The stem cell unit works to standardize all aspects of the culture process and has created a database which hESC lines, adult stem cells, and induced pluripotent stem cells may be compared. 

​

​

(Text 11, 12)

The International Cord Blood Society(ICBS) is a nonprofit organization working towards advancing stem cell research in umbilical cord blood stem cells. ICBS is dedicated to educating the public towards the benefits of cryopreserving umbilical cord blood stem cells. ICBS has served the healthcare community greatly in its creation of a forum for information sharing and continuing education for professionals. The ICBS website is a platform for new and existing research, discussion, and general publications of cord blood stem cell research.

​

(Text 13)

The California Institute for Regenerative Medicine(CIRM) mission under the authorization of Proposition 71 is "accelerating stem cell treatments to patients with unmet medical needs". Proposition 71 was voted in by California voters to establish the right to conduct stem cell research in the state of California on November 2, 2004. CIRM monitors and funds all areas of stem cell research in the state that show the potential to accelerate treatment to patients in need. CIRM funded research may result in therapies involving transplanting the cells, drugs that were found through modeling diseases in a petri dish, and diagnostics that help doctors diagnose and treat diseases more effectively.

​

​

Text 14